{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T11:10:56Z","timestamp":1770462656895,"version":"3.49.0"},"reference-count":36,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1055\/s-0043-1768938","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T01:17:35Z","timestamp":1683767855000},"page":"303-306","source":"Crossref","is-referenced-by-count":4,"title":["Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?"],"prefix":"10.1055","volume":"50","author":[{"given":"Francesco","family":"Marongiu","sequence":"additional","affiliation":[{"name":"Haemostasis and Thrombosis Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy"},{"name":"Fondazione Arianna Anticoagulazione, Bologna, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Barcellona","sequence":"additional","affiliation":[{"name":"Haemostasis and Thrombosis Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0140-6736(09)60994-6","article-title":"Mitral stenosis","volume":"374","author":"Y Chandrashekhar","year":"2009","journal-title":"Lancet"},{"key":"ref2","volume-title":"Rheumatic Fever and Rheumatic Heart Disease: Report of WHO Expert Consultation, Geneva, 29 October to 1 November 2001","author":"World Health Organization (WHO)","year":"2004"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5334\/gh.807","article-title":"Meta-analysis of the incidence, prevalence, and correlates of atrial fibrillation in rheumatic heart disease","volume":"15","author":"J J Noubiap","year":"2020","journal-title":"Glob Heart"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"C T Ruff","year":"2014","journal-title":"Lancet"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","article-title":"2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"74","author":"C T January","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/euv288","article-title":"Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial","volume":"18","author":"R De Caterina","year":"2016","journal-title":"Europace"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJMoa2209051","article-title":"Rivaroxaban in rheumatic heart disease-associated atrial fibrillation","volume":"387","author":"S J Connolly","year":"2022","journal-title":"N Engl J Med"},{"issue":"04","key":"ref8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"S Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref9","first-page":"298","article-title":"The future of anticoagulation clinics: a journey to thrombosis centers?","volume":"90","author":"F Marongiu","year":"2005","journal-title":"Haematologica"},{"issue":"10","key":"ref10","first-page":"1081","article-title":"Patient education and oral anticoagulant therapy","volume":"87","author":"D Barcellona","year":"2002","journal-title":"Haematologica"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijcard.2021.03.003","article-title":"Patients' adherence to oral anticoagulants therapy: comparison between vitamin K antagonists and direct oral anticoagulants","volume":"333","author":"D Barcellona","year":"2021","journal-title":"Int J Cardiol"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1056\/NEJMe2210187","article-title":"Anticoagulation in atrial fibrillation and rheumatic heart disease","volume":"387","author":"G YH Lip","year":"2022","journal-title":"N Engl J Med"},{"issue":"08","key":"ref13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0021-9290(94)00154-V","article-title":"The effect of varying degrees of stenosis on the characteristics of turbulent pulsatile flow through heart valves","volume":"28","author":"D Bluestein","year":"1995","journal-title":"J Biomech"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0002-9149(00)01007-9","article-title":"Predictors of left atrial spontaneous echo contrast and thrombi in patients with mitral stenosis and atrial fibrillation","volume":"86","author":"E Gonz\u00e1lez-Torrecilla","year":"2000","journal-title":"Am J Cardiol"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0167-5273(00)00415-0","article-title":"Left atrial spontaneous echo contrast in patients with rheumatic mitral valve stenosis in sinus rhythm: relationship to mitral valve and left atrial measurements","volume":"77","author":"A K Agarwal","year":"2001","journal-title":"Int J Cardiol"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0735-1097(93)90688-W","article-title":"Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation","volume":"21","author":"I W Black","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0003319706297917","article-title":"Coagulation, fibrinolytic system activation and endothelial dysfunction in patients with mitral stenosis and sinus rhythm","volume":"58","author":"S Topaloglu","year":"2007","journal-title":"Angiology"},{"issue":"04","key":"ref18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0735-1097(02)02898-X","article-title":"Spontaneous echo contrast video density is flow-related and is dependent on the relative concentrations of fibrinogen and red blood cells","volume":"41","author":"R Rastegar","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0040-1718889","article-title":"The role of red blood cells in hemostasis","volume":"47","author":"A A Alamin","year":"2021","journal-title":"Semin Thromb Hemost"},{"issue":"07","key":"ref20","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1538-7836.2012.04758.x","article-title":"Platelet- and erythrocyte-derived microparticles trigger thrombin generation via factor XIIa","volume":"10","author":"P E Van Der Meijden","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1182\/blood.2019001643","article-title":"Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways","volume":"135","author":"D F Noubouossie","year":"2020","journal-title":"Blood"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/jth.14360","article-title":"Red blood cells: the forgotten player in hemostasis and thrombosis","volume":"17","author":"J W Weisel","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.thromres.2013.01.023","article-title":"The role of the red cell membrane in thrombin generation","volume":"131","author":"M F Whelihan","year":"2013","journal-title":"Thromb Res"},{"issue":"12","key":"ref24","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.repc.2021.08.016","article-title":"Association of spontaneous echo contrast with systemic immune inflammation index in patients with mitral stenosis","volume":"41","author":"S Kelesoglu","year":"2022","journal-title":"Rev Port Cardiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"933913","DOI":"10.3389\/fcvm.2022.933913","article-title":"Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: a systematic review and meta-analysis","volume":"9","author":"Z Ye","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"05","key":"ref26","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)63415-3","article-title":"Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions","volume":"165","author":"L Guilherme","year":"2004","journal-title":"Am J Pathol"},{"issue":"06","key":"ref27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/joa3.12428","article-title":"Role of inflammation in initiation and maintenance of atrial fibrillation in rheumatic mitral stenosis - an analytical cross-sectional study","volume":"36","author":"G Sharma","year":"2020","journal-title":"J Arrhythm"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.179.4.1253","article-title":"Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees","volume":"179","author":"T van der Poll","year":"1994","journal-title":"J Exp Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","article-title":"Inflammation and coagulation","volume":"38","author":"M Levi","year":"2010","journal-title":"Crit Care Med"},{"issue":"13","key":"ref30","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"J W Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"issue":"08","key":"ref31","doi-asserted-by":"crossref","first-page":"e002322","DOI":"10.1161\/JAHA.115.002322","article-title":"Dabigatran is less effective than warfarin at attenuating mechanical heart valve-induced thrombin generation","volume":"4","author":"I H Jaffer","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40262-013-0100-7","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban","volume":"53","author":"W Mueck","year":"2014","journal-title":"Clin Pharmacokinet"},{"issue":"13","key":"ref33","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"V Pengo","year":"2018","journal-title":"Blood"},{"issue":"03","key":"ref34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-0042-1760333","article-title":"Evolution of antiphospholipid syndrome","volume":"49","author":"D RJ Arachchillage","year":"2023","journal-title":"Semin Thromb Hemost"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/ijlh.14043","article-title":"Mixing factor Xa and thrombin inhibiting direct oral anticoagulants produces a synergistic prolonging effect on most clotting tests","volume":"45","author":"T Exner","year":"2023","journal-title":"Int J Lab Hematol"},{"issue":"S 02","key":"ref36","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/S0049-3848(16)30363-2","article-title":"Factor XI and factor XII as targets for new anticoagulants","volume":"141","author":"J I Weitz","year":"2016","journal-title":"Thromb Res"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1768938.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T11:48:08Z","timestamp":1730807288000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1768938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":36,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2024,2,5]]},"published-print":{"date-parts":[[2024,3]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1768938","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]}}}